Ohio Attorney General Mike DeWine says the manufacturer of a drug overdose antidote will provide rebates for public agencies buying the drug over the next year.
California-based Amphastar Pharmaceuticals Inc. manufactures naloxone. DeWine had asked Amphastar for the rebates after the cost of supplies of the drug nearly doubled.
Under the deal announced Wednesday, Amphastar will provide a $6 rebate for each naloxone syringe bought by a non-federal public entity in Ohio in the next 12 months.
Amphastar has reached a similar rebate agreement with New York. The company says it’s happy to have reached an agreement that will help Ohio save lives.
The news comes as the Ohio House was expected to approve a bill later Wednesday expanding the antidote’s use across the state.